EBIM
MD icon

Eagle Boston Investment Management’s Pediatrix Medical MD Stock Holding History

Eagle Boston Investment Management’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$650K Sell
25,798
-40,094
-61% -$1.08M 0.74% 69
2019
Q1 		$1.79M Sell
65,892
-15,195
-19% -$509K 0.78% 58
2018
Q4 		$2.67M Sell
81,087
-176,016
-68% -$7.08M 0.93% 45
2018
Q3 		$12M Buy
257,103
+12,595
+5% +$578K 1.08% 40
2018
Q2 		$10.6M Buy
244,508
+10,385
+4% +$498K 0.98% 50
2018
Q1 		$13M Buy
234,123
+11,311
+5% +$620K 1.3% 19
2017
Q4 		$11.9M Buy
222,812
+27,093
+14% +$1.28M 1.19% 24
2017
Q3 		$8.67M Buy
195,719
+4,083
+2% +$194K 0.89% 54
2017
Q2 		$11.6M Buy
191,636
+21,895
+13% +$1.3M 1.26% 26
2017
Q1 		$11.8M Buy
169,741
+8,920
+6% +$620K 1.32% 22
2016
Q4 		$10.7M Sell
160,821
-370
-0.2% -$24.1K 1.28% 24
2016
Q3 		$10.7M Buy
161,191
+2,339
+1% +$160K 1.37% 21
2016
Q2 		$11.5M Buy
158,852
+4,185
+3% +$288K 1.56% 15
2016
Q1 		$9.99M Buy
154,667
+3,821
+3% +$253K 1.38% 19
2015
Q4 		$10.8M Sell
150,846
-7,772
-5% -$575K 1.52% 13
2015
Q3 		$12.2M Sell
158,618
-19,384
-11% -$1.56M 1.63% 12
2015
Q2 		$13.2M Sell
178,002
-85,069
-32% -$6.12M 1.66% 12
2015
Q1 		$19.1M Sell
263,071
-79,432
-23% -$5.52M 1.6% 13
2014
Q4 		$22.6M Sell
342,503
-81,986
-19% -$5M 1.49% 14
2014
Q3 		$23.3M Sell
424,489
-7,802
-2% -$443K 1.29% 22
2014
Q2 		$25.1M Sell
432,291
-14,709
-3% -$865K 1.25% 22
2014
Q1 		$27.7M Sell
447,000
-13,581
-3% -$790K 1.37% 20
2013
Q4 		$24.6M Buy
460,581
+87,337
+23% +$4.69M 1.19% 32
2013
Q3 		$18.6M Sell
373,244
-7,738
-2% -$378K 1.13% 32
2013
Q2 		$17.4M Buy
+380,982
New +$17.1M 1.16% 29

Other funds holding MD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
PCP
P2 Capital Partners New York $246M AUM 17.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Eagle Boston Investment Management's MD Position: Q2 2019 in Review

Eagle Boston Investment Management reduced its Pediatrix Medical (MD) stake by 61% in Q2 2019, selling an estimated $1.08M and leaving 25,798 shares worth $650K. The position accounts for 0.74% of the portfolio, ranked #69.

Eagle Boston Investment Management first reported a position in MD in Q2 2013 and has held it in 25 quarters since. The position peaked at $27.7M in Q1 2014. 247 funds tracked by Wall St. Rank hold MD as of Q2 2019.

  • Eagle Boston Investment Management held 25,798 shares of Pediatrix Medical worth $650K as of Q2 2019.
  • Eagle Boston Investment Management sold 40,094 Pediatrix Medical shares in Q2 2019, an estimated $1.08M.
  • Pediatrix Medical made up 0.74% of Eagle Boston Investment Management's portfolio in Q2 2019, its #69 holding.
  • Eagle Boston Investment Management first reported a position in Pediatrix Medical in Q2 2013 and has held it in 25 quarters since.
  • Eagle Boston Investment Management's Pediatrix Medical position peaked at $27.7M in Q1 2014.
  • 247 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2019.

Based on Eagle Boston Investment Management's 13F filing for Q2 2019, filed 5 Aug 2019.